| Ytd | 61.79% | |
| 1y | 75.80% |
| Open | 9.80 | Prev Close | 9.98 | Low | 9.68 | High | 9.96 | Mkt Cap | 90.37M |
| Vol | 10.04K | Avg Vol | 28.83K | EPS | 0.07 | P/E | 142.14 | Forward P/E | -42.82 |
| Beta | 0.57 | Short Ratio | 0.23 | Inst. Own | 14.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 10.51 | 200-d Avg | 8.22 | 1yr Est | 14.00 |
ICCC's Q2 sales rise 11.5% y/y, but margins contract. A $2-million legal settlement boosts profit as
ImmuCell Corporation (NASDAQ: ICCC - Get Free Report)'s stock price crossed above its 200-day moving
ImmuCell Corporation (ICCC) Q2 2026 Earnings Call Transcript
ImmuCell (NASDAQ:ICCC) released second-quarter financial results and hosted an earnings call on Frid
ImmuCell NASDAQ: ICCC reported higher second-quarter sales and earnings as domestic demand for its c
ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.20 per share. This is a 233.33 percent incr
PORTLAND, Maine, Aug. 13, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” o
PORTLAND, Maine, Aug. 06, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” o
ImmuCell's main value driver is First Defense. In my view, this is their core franchise and has real
ICCC reports an 11.5% rise in preliminary Q2 sales, driven by robust U.S. demand and improved produc
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), an animal health
PORTLAND, Maine, July 09, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” o
ImmuCell's premium valuation is backed by rising output, First Defense share gains and a sizable unt
ICCC posts record Q1 sales and 34% earnings growth as demand for its First Defense calf-health produ
ImmuCell NASDAQ: ICCC reported a record first quarter of 2026, with management saying the company's
ImmuCell Corporation (ICCC) Q1 2026 Earnings Call Transcript
PORTLAND, Maine, May 14, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or
PORTLAND, Maine, May 07, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or
Goldman Sachs, NextEra Energy and Shopify lead top stock reports, highlighting strong gains, expandi
PORTLAND, Maine, April 13, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”
PORTLAND, Maine, April 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”
ImmuCell Corporation (NASDAQ: ICCC - Get Free Report) crossed above its 200-day moving average durin
PORTLAND, Maine, March 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl
On Friday, 199 companies reached new 52-week lows.
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings
Thursday's session saw 337 companies set new 52-week lows.
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is likely to report earnings for its f
On Tuesday, 400 companies set new 52-week lows.
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarte
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report
During Friday's morning session, 57 stocks hit new 52-week highs.